Related Experiment Video
Updated: Jul 23, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Peri- and Post-procedural Anticoagulation with Left Atrial Appendage Occlusion Devices
Pradyumna Agasthi1, Sai Harika Pujari2
1Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA.
Insights
Left atrial appendage occlusion is an alternative stroke prevention strategy for patients with atrial fibrillation and high bleeding risk. This review covers procedural anticoagulation, complications, and device-related thrombosis risks.
Area of Science:
- Cardiology
- Interventional Cardiology
- Medical Device Technology
Background:
- Atrial fibrillation increases stroke risk due to left atrial appendage thrombus formation.
- Anticoagulation is standard for stroke prevention but carries bleeding risks.
- Percutaneous left atrial appendage occlusion (LAAO) offers an alternative for high-risk patients.
Purpose of the Study:
- To review peri- and post-procedural anticoagulation/antithrombotic therapy after LAAO.
- To discuss complications, device-related thrombosis, and incomplete occlusion risks.
- To identify literature limitations and gaps in LAAO management.
Main Methods:
- Literature review of current studies on LAAO.
- Analysis of anticoagulation protocols and outcomes.
- Examination of procedural complication rates and thrombosis risks.
Main Results:
- Standardized peri- and post-procedural antithrombotic strategies are crucial for LAAO success.
- Device-related thrombosis and incomplete occlusion are significant risks requiring monitoring.
- Optimal antithrombotic regimens post-LAAO are still under investigation.
Conclusions:
- LAAO is a viable stroke prevention option for select atrial fibrillation patients.
- Careful management of antithrombotic therapy and monitoring for complications are essential.
- Further research is needed to optimize LAAO protocols and long-term outcomes.
Abstract:
In patients with atrial fibrillation and high stroke risk, anticoagulation with direct oral anticoagulants or vitamin K antagonists is the standard of care for stroke prevention. The benefit of anticoagulation is driven by attenuating the risk of thrombus formation in the left atrial appendage. Percutaneous left atrial appendage occlusion offers an alternative therapeutic strategy for stroke prevention in patients with high bleeding risk or contraindications for long-term anticoagulation. This review of the current literature delineates the standard protocols of peri- and post-procedural anticoagulation/antithrombotic therapy after left atrial appendage occlusion, the complications of the procedure, and the risk of device-related thrombosis and of incomplete occlusion of the appendage. Finally,the limitations and gaps in the literature are identified.
Related Concept Videos
Cardiac Catheterization III: Left Heart Catheterization
Venous Thrombosis III: Interprofessional Care
Cardiac Catheterization II: Right Heart Catheterization
Cardiac Catheterization I: Pre-Procedure Overview
Anticoagulant Drugs: Low-Molecular-Weight Heparins

